Department of Thoracic Surgery, Med+X Center for Informatics, West China Hospital, Sichuan University.
West China Biomedical Big Data Center, Med+X Center for Informatics, West China Hospital, Sichuan University, Chengdu, China.
Int J Surg. 2024 Sep 1;110(9):5802-5817. doi: 10.1097/JS9.0000000000001777.
Currently, mediastinoscopy-assisted esophagectomy (MAE) and thoracoscope-assisted esophagectomy (TAE) represent two prevalent forms of minimally invasive esophagectomy extensively employed in the management of esophageal cancer (EC). The aim of this meta-analysis is to assess and compare these two surgical approaches concerning perioperative outcomes and long-term survival, offering valuable insights for refining surgical strategies and enhancing patient outcomes in this field.
Adhering to PRISMA guidelines, the authors systematically searched PubMed, Web of Science, Cochrane Library, Embase, and CNKI databases until 1 March 2024, for studies comparing MAE and TAE. Outcomes of interest included perioperative outcomes (intraoperative outcomes, postoperative recovery, postoperative complications) and survival rates. Statistical analyses were performed using RevMan 5.4, with heterogeneity dictating the use of fixed or random-effects models.
A total of 21 relevant studies were finally included. MAE was associated with significantly shorter operation times [mean difference (MD)=-59.58 min, 95% CI: -82.90 to -36.26] and less intraoperative blood loss (MD=-68.34 ml, 95% CI: -130.45 to -6.23). However, MAE resulted in fewer lymph nodes being dissected (MD=-3.50, 95% CI: -6.23 to -0.78). Postoperative recovery was enhanced following MAE, as evidenced by reduced hospital stays and tube times. MAE significantly reduced pulmonary complications [odds ratio (OR)=0.59, 95% CI: 0.44, 0.81] but increased the incidence of recurrent laryngeal nerve injury (OR=1.84, 95% CI: 1.30, 2.60). No significant differences were observed in anastomotic leakage, chylothorax, cardiac complications, wound infections, and gastric retention between MAE and TAE. The long-term survival outcomes showed no statistical difference [hazard ratio (HR)=1.05, 95% CI: 0.71, 1.54].
MAE offers advantages in reducing operation time, blood loss, and specific postoperative complications, particularly pulmonary complications, with a shorter recovery period compared to TAE. However, it poses a higher risk of recurrent laryngeal nerve injury and results in fewer lymph nodes being dissected. No difference in long-term survival was observed, indicating that both techniques have distinct benefits and limitations. These findings underscore the need for personalized surgical approaches in EC treatment, considering individual patient characteristics and tumor specifics.
目前,胸腔镜辅助食管切除术(TAE)和纵隔镜辅助食管切除术(MAE)是两种广泛应用于食管癌(EC)治疗的微创食管切除术。本荟萃分析旨在评估和比较这两种手术方法在围手术期结果和长期生存方面的情况,为该领域的手术策略优化和患者预后改善提供有价值的见解。
作者按照 PRISMA 指南,系统地检索了 PubMed、Web of Science、Cochrane 图书馆、Embase 和中国知网数据库,截至 2024 年 3 月 1 日,以比较 MAE 和 TAE 的研究。感兴趣的结局包括围手术期结局(术中结局、术后恢复、术后并发症)和生存率。使用 RevMan 5.4 进行统计学分析,根据异质性决定使用固定效应模型或随机效应模型。
最终纳入了 21 项相关研究。MAE 组手术时间明显缩短[均数差(MD)=-59.58 分钟,95%可信区间(CI):-82.90 至 -36.26],术中出血量减少(MD=-68.34 毫升,95% CI:-130.45 至 -6.23)。然而,MAE 组淋巴结清扫数目减少(MD=-3.50,95% CI:-6.23 至 -0.78)。MAE 术后恢复更快,表现为住院时间和置管时间缩短。MAE 显著降低了肺部并发症的发生率[比值比(OR)=0.59,95% CI:0.44,0.81],但增加了喉返神经损伤的发生率(OR=1.84,95% CI:1.30,2.60)。MAE 和 TAE 组在吻合口漏、乳糜胸、心脏并发症、伤口感染和胃潴留方面无显著差异。长期生存结局无统计学差异[风险比(HR)=1.05,95% CI:0.71,1.54]。
与 TAE 相比,MAE 具有减少手术时间、出血量和特定术后并发症(尤其是肺部并发症)的优势,术后恢复更快。然而,MAE 会增加喉返神经损伤的风险,并导致淋巴结清扫数目减少。两种技术在长期生存方面没有差异,这表明它们各有优缺点。这些发现强调了在 EC 治疗中需要个体化手术方法,考虑患者的个体特征和肿瘤特异性。